Covidien launches hernia repair device; Teleflex gets U.S. Army grant;

Medical Device News

@FierceMedDev: IPOs: Sientra goes for $75M, while Nevro nerves up for $100M. Report | Follow @FierceMedDev

@VarunSaxena2: Here's my pernicious article. Read it are your own risk. ICYMI yesterday | Follow @VarunSaxena2

@EmilyWFierce: Find out which companies struck gold in the pharma M&A frenzy in FiercePharma's latest special report. Report | Follow @EmilyWFierce

> Ortho-Clinical Diagnostics, makers of in vitro diagnostic products, received a CE mark for the Ortho Vision Analyzer, an interactive and fully automated analyzer for transfusion medicine laboratories. Release

> Covidien ($COV) launched ReliaTack, a laparoscopic hernia repair device with 65-degree articulation that provides surgeons with greater access to weak spots within the abdominal wall. Release

> Teleflex, a medical device company concentrating on critical care and surgery, was awarded $2.1 million in a research grant from the U.S. Army's Telemedicine and Advanced Technology Research Center (TATRC) to develop an anti-biofilm medical device. Release

> Leica Biosystems, an anatomical pathology solutions and cancer diagnostics company within Danaher ($DHR), signed an agreement to acquire Devicor, a breast biopsy procedures device player. Release

Biotech News

@FierceBiotech: $AMGN, $SNY and Ono band together for open-source R&D. Article | Follow @FierceBiotech

@JohnCFierce: Amgen adds up to 1,100 new job cuts to its global restructuring plan - Wall Street loves it, shares up 5%. News | Follow @JohnCFierce

@DamianFierce: $RNA CEO on $SRPT's setback: "We are all in this together." More from CNBC | Follow @DamianFierce

@EmilyMFierce: Salk's 100th: Anti-Vaccination Would Trouble Polio Hero. More from LiveScience | Follow @EmilyMFierce

> Novartis chief Jimenez predicts 'multi-blockbuster' success for star heart drug. Article

> Advent joins the parade of new biotech funds with $235M war chest. Item

> Receptos' lead drug scores another promising PhII--this time for ulcerative colitis. News

> Bristol-Myers nabs a HER2 cancer drug in $475M option deal with F-star. Report

Pharma News

@FiercePharma: Tops in FierceAnimalHealth: Lilly divests U.S. animal health assets to Virbac ahead of Novartis deal. Story | Follow @FiercePharma

@EricPFierce: Ranbaxy's New Jersey plant comes through for drugmaker. More | Follow @EricPFierce

@CarlyHFierce: Our newest special report is live! Pharma's top 10 M&A deals of H1 2014. Feature | Follow @CarlyHFierce

> Big relief for Lilly, Boehringer as judge slashes $9B Actos award by 99%. Report

> Pfizer beats the Street's Q3 expectations but stays mum on AZ deal. Article

> Novartis gets 4% sales lift as 'growth products' make good on their label. Story

> Looming trouble in Sanofi's diabetes biz turns up the heat on CEO. More

Biotech Research News

> Government halts research on dangerous airborne pathogens. Item

> Toxin-producing stem cells designed to kill brain cell tumors. Report

> Brain cells reprogrammed from skin cells offer treatment hope for Huntington's. Story

> Case Western, Janssen, Oncodesign scientists ID anti-inflammatory compounds. More

> Protein discovery could help kill stubborn latent HIV. Article

Pharma Manufacturing News

> Australia's CSL gets three Novartis vaccine plants in $275M deal. News

> Ranbaxy's New Jersey plant comes through for drugmaker. Item

> Hikma gets FDA warning letter for plant in Portugal. More

> Fujifilm adding Texas-based vaccine specialist to its fold. Story

> U.S. Attorney subpoenas Novo for info on Denmark plant. Article

Suggested Articles

The FDA disclosed over 60 safety reports related to intra-aortic balloon pumps manufactured by Maquet and Datascope, following a recall this summer.

Truvian Sciences raised $27.1 million to fuel the development of its benchtop blood tester, bringing the company’s total funding to $46.3 million.

The money will fund work to develop polymers in multiple indications and an associated U.S. expansion.